BROUGHT TO YOU BY:

ETF Portfolio Builder

New

ETF Portfolio Builder

New

PBEvsTMEDETF Comparison

ETF 1

PBE

Invesco Dynamic Biotechnology & Genome ETF

This fund is part of

BioTech & Genomics

+0.33%

Full PBE fund page

VS

ETF 2

TMED

T. Rowe Price Health Care ETF

This fund is part of

US Health Care

-0.12%

Full TMED fund page

Invesco Dynamic Biotechnology & Genome ETF (PBE) belongs to the BioTech & Genomics segment. T. Rowe Price Health Care ETF (TMED) is part of the US Health Care segment. PBE's top 1 sector exposures are Healthcare. In contrast, TMED's top sector exposures are Healthcare, Consumer Non-Cyclicals and Non-Corporate. PBE is more expensive with a Total Expense Ratio (TER) of 0.59%, versus 0.44% for TMED. PBE is up 14.59% year-to-date (YTD) with +$114M in YTD flows. TMED performs worse with 14.05% YTD performance, and +$13M in YTD flows. Run a side-by-side ETF comparison of PBE and TMED below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios. Discover our library of Model portfolios

PBE vs TMED performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Data Services

Historic performance and flows

Data as of 09/10/2026

		1M	3M	YTD	1Y	3Y	5Y
Perf.	PBE TMED	-0.70%-4.30%	+12.83%+7.93%	+14.59%+14.05%	+35.63%+32.01%	+57.51%n/a	+23.66%n/a
Flows	PBE TMED	+$44M+$4M	+$117M+$10M	+$114M+$13M	+$113M+$15M	+$62M-	+$64M-

Volatility and drawdown

		3M	1Y	3Y	5Y
Volatility	PBE TMED	+19.58%+17.95%	+19.33%+18.49%	+20.48%n/a	+22.57%n/a
Max drawdown	PBE TMED	-5.73%-7.73%	-11.70%-11.09%	-22.21%n/a	-33.32%n/a
Max drawdown duration	PBE TMED	7d22d	166d125d	324dn/a	1509dn/a

Trading data

Create an account to view trading data

Join for free

	PBE	TMED
Last sale 9/11/2026 at 1:30 PM	$92.91	$33.80
Previous close 09/10/2026	$93.03	$33.89
Consolidated volume 09/10/2026
Average volume 30 days
Average discount or premium 30 days
Average Bid/Ask spread 30 days

Replication quality

Data as of August 31, 2026

1-year trailing difference

Create an account to view replication metrics

Join for free

TMED

is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free

	PBE	TMED
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst

Main metrics

Last update 9/11/2026 at 1:30 PM

Live

Closed

	PBE	TMED
Last price	$92.91	$33.80
1D performance	-0.13%	-0.25%
AuM	$405.87 M	$32.16 M
E/R	0.59%	0.44%

Characteristics

	PBE	TMED
Management strategy	Passive	Active
Provider	Invesco	T. Rowe Price
Benchmark	Dynamic Biotech & Genome Intellidex Index	-
N° of holdings	30	97
Asset class	Equities	-
Trailing 12m distribution yield	Join	Join
Inception date	June 23, 2005	June 11, 2025
ESG	No	No

More PBE data on Trackinsight

More TMED data on Trackinsight

Exposure

Countries

PBE

USA

97.13%

Other

2.87%

TMED

USA

93.59%

Other

6.41%

Sectors

PBE

Healthcare

100%

Other

0%

TMED

Healthcare

98.58%

Other

1.42%

Diversification

PBE

Total weight of top 15 holdings out of 15

61.32%

TMED

Total weight of top 15 holdings out of 15

61.11%

Top 15 holdings

Data as of July 31, 2026

PBE

Amgen, Inc.

5.16%

Vertex Pharmaceuticals, Inc.

4.96%

Royalty Pharma Plc

4.91%

Regeneron Pharmaceuticals, Inc.

4.90%

Biogen, Inc.

4.85%

Gilead Sciences, Inc.

4.44%

Alnylam Pharmaceuticals, Inc.

4.34%

United Therapeutics Corp.

4.06%

CareDx, Inc.

4.01%

Bio-Techne Corp.

3.66%

Illumina, Inc.

3.27%

Vericel Corp.

3.25%

Protagonist Therapeutics, Inc.

3.24%

Incyte Corp.

3.19%

Veracyte, Inc.

3.07%

TMED

Eli Lilly & Co.

16.65%

UnitedHealth Group, Inc.

5.89%

Thermo Fisher Scientific, Inc.

4.44%

Alnylam Pharmaceuticals, Inc.

4.11%

Gilead Sciences, Inc.

3.76%

Danaher Corp.

3.58%

Cencora, Inc.

3.30%

Insulet Corp.

2.73%

Agilent Technologies, Inc.

2.69%

DexCom, Inc.

2.66%

Dyne Therapeutics, Inc.

2.60%

Stryker Corp.

2.49%

West Pharmaceutical Services, Inc.

2.29%

Waters Corp.

2.20%

McKesson Corp.

1.72%

Frequently asked questions about PBE and TMED

How have the PBE and TMED ETFs performed in 2026?

As of September 10, 2026, PBE is up 14.59% year-to-date (YTD), while TMED has returned 14.05%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: PBE or TMED?

Year-to-date, the PBE ETF saw +$114M in flows, compared to +$13M for TMED.

Which ETF is more volatile: PBE or TMED?

Over the past year, PBE had a volatility of 19.33%, while TMED experienced 18.49%.

Which ETF is bigger: PBE or TMED?

As of September 10, 2026, PBE holds $405.87 M in assets under management (AUM), while TMED manages $32.16 M.

What sectors do the PBE and TMED ETFs invest in?

PBE leans toward sectors like Healthcare. Meanwhile, TMED focuses on Healthcare.

What are the top holdings of the PBE ETF and TMED ETF?

PBE top holdings include Amgen, Inc., Vertex Pharmaceuticals, Inc. and Royalty Pharma Plc. TMED holds in its top three: Eli Lilly & Co., UnitedHealth Group, Inc. and Thermo Fisher Scientific, Inc..

PBEvsTMEDETF Comparison

Invesco Dynamic Biotechnology & Genome ETF

T. Rowe Price Health Care ETF

PBE vs TMED performance and flow charts

Performance

Cumulative Flows

Get all the metrics on this page, and more, through a reliable ETF data feed

Countries

Sectors

Diversification

Top 15 holdings

How have the PBE and TMED ETFs performed in 2026?

As of September 10, 2026, PBE is up 14.59% year-to-date (YTD), while TMED has returned 14.05%. That puts PBE better performer ahead so far this year.

Which ETF is attracting more investor money: PBE or TMED?

Year-to-date, the PBE ETF saw +$114M in flows, compared to +$13M for TMED.

Which ETF is more volatile: PBE or TMED?

Over the past year, PBE had a volatility of 19.33%, while TMED experienced 18.49%.

Which ETF is bigger: PBE or TMED?

As of September 10, 2026, PBE holds $405.87 M in assets under management (AUM), while TMED manages $32.16 M.

What sectors do the PBE and TMED ETFs invest in?

PBE leans toward sectors like Healthcare. Meanwhile, TMED focuses on Healthcare.

What are the top holdings of the PBE ETF and TMED ETF?

PBE top holdings include Amgen, Inc., Vertex Pharmaceuticals, Inc. and Royalty Pharma Plc. TMED holds in its top three: Eli Lilly & Co., UnitedHealth Group, Inc. and Thermo Fisher Scientific, Inc..

Which ETF is more diversified: PBE or TMED?

PBE holds 30 securities with 61.32% of its assets in the top 15. TMED has 97 securities and a top 15 weight of 61.11%.

Expert-Built ETF Portfolios, All in One Place